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cAMP receptors mediate signal  transduction  path- 
ways during development in Dictyostelium. A cAMP 
receptor (cAR1) has been cloned and sequenced (Klein, 
P., Sun, T. J., Saxe, C. L., Kimmel, A.  R., Johnson, R. 
L., and Devreotes, P. N. (1988) Science 241,  1467- 
1472)  and recently  several  other CAR genes have been 
identified (Saxe, C. L., Johnson, R., Devreotes, P. N., 
andKimmel, A. R. (1991a) Dev. Genet. 12,6-13;  Saxe, 
C. L., Johnson, R. L., Devreotes, P. N., and Kimmel, 
A. R. (1991b) Genes Dev. 6,143). We have expressed 
three receptor subtypes, cAR1, cAR2, and cAR3, in 
growing cells and  have  investigated their  affinity  and 
pharmacological specificity in a series of [‘HICAMP 
binding studies. In phosphate buffer,  there  were  two 
affinity  states of about 30 and 300 nM for CAR1 and 
20 and 600 nM for cAR3 but no detectable affinity  for 
cAR2. In  the presence of 3 M ammonium sulfate, there 
was one affinity  state of 4 nM for CAR1 and 11 nM for 
cAR2 and two  affinity  states of approximately  4  and 
200 n M  for cAR3. The  relative  affinities of 14 cyclic 
nucleotide derivatives were tested for each CAR in 
ammonium sulfate. These studies suggest a model  (Van 
Haastert, P. J. M., and Kien, E. (1983) J. Biol. Chem. 
268,  9636-9642)  in which CAMP binds  to all three 
receptor  subtypes by maintaining hydrogen bond in- 
teractions at the N6 and 03’ positions. Interactions at 
the exocyclic oxygens of cAMP varied between the 
receptors; cAR2 and cAR3 lacked a stereoselective 
interaction at the  axial oxygen which was  present  in 
cAR1. The cleft, which binds the adenine ring of 
CAMP, was hydrophobic in CAR1 and cAR3 but  rela- 
tively  polar in cAR2. The  analog specificity of CAR1 
and cAR3 in phosphate buffer  was  similar  to that meas- 
ured  in ammonium sulfate though the  derivatives’  rel- 
ative  affinity  to cAMP was reduced. We conclude that 
these cAMP receptor  subtypes  can be distinguished by 
distinct pharmacological properties which will allow 
selective activation of each CAR during development. 
Extracellular cAMP acts  as a primary messenger at several 
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points  in the developmental program of Dictyostelium discoi- 
deum. During early aggregation, intermittent stimulation with 
cAMP coordinates the accumulation of individual amoebae 
to form organization centers (Devreotes, 1982) and to regulate 
the expression of various early genes (reviewed by Kessin 
(1988)). At the mound stage, induction of prespore and the 
early stages of prestalk gene expression require persistent 
exposure to micromolar concentrations of cAMP (reviewed 
by Gerisch (1987)). Cell differentiation into at least four cell 
types (Williams et d., 1989) results  in the final multicellular 
structure, the fruiting body. 
Cell surface cAMP binding sites, which are  present 
throughout the development cycle of Dictyostelium, are most 
abundant  during early aggregation (Schaap and Spek, 1984; 
Schenk et al., 1991). At this stage, the cell surface receptors 
are coupled to G-proteins which, when stimulated, activate a 
variety of effector enzymes. Ligand stimulation of cAMP 
receptors initiates a signal transduction cascade to cause 
increases of second messengers, such as intracellular cAMP 
and  cGMP,  and permit cell-cell signaling. In addition, cAMP 
stimulation causes cytoskeletal changes, such as  actin polym- 
erization and myosin phosphorylation, which enable chemo- 
taxis (reviewed in Devreotes (1982)) Van Haastert (1991)). 
A cAMP receptor (cAR1)’ has been cloned and like other 
G-protein-coupled receptors found in mammals and yeast, its 
coding sequence predicts a protein with seven putative trans- 
membrane domains and a cytoplasmic C terminus (Klein et 
al., 1988). Recently, three  additional cAMP receptors (cAR2, 
cAR3, and cAR4)  have  been cloned and sequenced. Members 
of this family of receptor subtypes share approximately 60% 
identity within their transmembrane and loop regions but 
have distinct  C-terminal domains (Saxe et al., 1991a, 1991b). 
The developmental regulation of the major mRNA of each 
CAR is unique, but  there is some overlap between each. CAR1 
expression is low during growth, peaks during early aggrega- 
tion, and then subsides (Klein et aL, 1987). cAR2 mRNA, 
which is enriched in  prestalk cells, is expressed after 15 h of 
development while  cAR3  mRNA is detected earlier a t  approx- 
imately 10 h of development (Saxe et al., 1991a). Cells  which 
lack CAR1 as a consequence of antisense RNA expression 
(Klein et al., 1988; Sun et al., 1990) or gene disruption (Sun 
and Devreotes, 1991) do not  enter  the developmental program 
and remain as individual amoebae. 
cAMP derivatives have been used to determine the analog 
* The abbreviations used are: CAR, cAMP receptor; PB,  phosphate 
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specificity of cell surface cAMP receptors (Van Haastert  and 
Kien, 1983) and  other CAMP-binding proteins in Dictyoste- 
lium (De Wit et al., 1982; Van Ments-Cohen and Van Haas- 
tert, 1989). These studies have shown that cAMP binds to 
surface receptors in aggregation stage cells in a manner dis- 
tinct from that of intracellular cAMP dependent protein 
kinase and cell surface phosphodiesterase. The pharmacolog- 
ical specificity for chemotaxis (Van Haastert, 1983), activa- 
tion of guanylate (Van Haastert  and Kien, 1983) and  aden- 
ylate cyclase (Theibert et al., 1986), induction of gene expres- 
sion (Oyama and Blumberg, 1986; Haribabu  and  Dottin, 1986; 
Gomer et al., 1986), and cell-type differentiation  (Schaap  and 
Van Driel, 1985) have all been demonstrated to match that 
for surface cAMP receptors. 
The presence of multiple CAR subtypes during development 
suggests that different cAMP receptors mediate separate 
physiological responses or signal transduction pathways. The 
affinity and cyclic nucleotide specificity of each CAR subtype 
may help to distinguish those functions that each receptor 
controls. Interactions between cAMP and each CAR subtype 
may vary and thereby provide insight into how the ligand is 
oriented  in each binding pocket. It also may  be possible to 
identify cAMP analogs which specifically activate or block 
one receptor subtype. 
We have expressed three cAMP receptor subtypes, cAR1, 
cAR2, and cAR3, in growing Dictyostelium cells and examined 
their biochemical and pharmacological properties. Since there 
are few endogenous receptors present during growth, each 
individually expressed CAR can be examined without inter- 
ference from other receptor subtypes. Cells expressing CAR1 
during growth have been described previously and found to 
have similiar biochemical characteristics to  the endogenous 
receptors in aggregation stage cells (Johnson et al., 1991). In 
this paper, we demonstrate that cAR1, cAR2, and cAR3 
represent a group of similar CAMP-binding proteins which 
have subtle differences in their  interaction with CAMP. Fur- 
thermore, it now should be possible to distinguish each recep- 
tor subtype during development on the basis of its relative 
cyclic nucleotide specificity. 
EXPERIMENTAL PROCEDURES 
Materials-The names and structures of the cAMP derivatives are 
shown in Fig. 1 and Table I, respectively. [8-3H]cAMP (1.92 TBq/ 
mmol) was obtained from Amersham Corp.; [2,8-3H]cAMP (1.65 
TBq/mmol) was obtained from Du Pont. CAMP, 6-Cl-PuRMP, 8-Br- 




FIG. 1. Structures of the cAMP derivatives 
Mannheim; 7-CH-CAMP was a generous gift of Dr.  R. Hanze (Upjohn 
CO.); w-0-CAMP, 3'-NH-cAMP,  5'-NH-cAMP, cBIMP, and 
PuRMP were synthesized; the synthesis of these analogs has been 
described previously (Jastorff and Freist, 1974; Morr et al., 1974; 
Murayama et al.,  1971; Yagura et al.,  1980, Baraniak et al., 1979) 
Conditions for Growth and Development-AX-3 cells were main- 
tained in HL-5 (Watts and Ashworth, 1970) in shaking culture. 
Transformants were maintained on Petri dishes in HL-5 with 20  pg/ 
ml G418 but transferred to shaking cultures for experiments. All cells 
were harvested during late log phase growth and washed once in 10 
mM KH2P04/Na2HP04 buffer (PB), pH 6.5. For development, AX-3 
cells were shaken in PB for 4 h at 2 X 107 cells/ml as described 
(Devreotes et al.,  1987). 
Construction and Transformation of Expression Vectors-The cre- 
ation of cells overexpressing CAR1 has been described (Johnson  et 
al.,  1991). A full-length cAR2 clone was isolated from a sheared, size- 
selected (2-5-kb range) genomic  Dictyostelium library (Lambda Zap, 
Stratagene; gift of Dr. H. Innis).' This 2-kb clone contains 158 bp of 
5'- and about 900 bp of 3"untranslated sequence and was shuttled 
into the EcoRI site of Bluescript KS+ (Stratagene). A full-length 
cAR3 clone, GR-6, was isolated from a  partial Sau3A Dictyostelium 
genomic library (PAT plasmid, gift of Dr. R. Firtel).3 This 1.7-kb 
clone, which contains 35 bp of 5'- and 40 bp of 3"untranslated 
sequence, was isolated from the parent plasmid by digesting with 
XbaI and SmaI. The inserts of cAR2 and cAR3  were  filled in with 
Klenow, BamHI linkers added, and cloned into  the BamHI  site of 
separate Bluescript vectors. cAR2 or cAR3  were then cloned into the 
expression construct, pB18 (gift of Dr. R. Firtel), by digesting with 
BamHI and ligating them into  the BglII site of pB18 in the sense 
orientation. These vectors or the parent  construct, pB18,  were trans- 
formed into AX-3 cells by electroporation as described (Dynes and 
Firtel, 1989). Stable  transformants were selected by resistance to 10 
or 20 pg/ml G418 in HL-5. Total transformants (cAR3) or clones 
(cAR2) were examined for CAR expression by their ability to bind 
[3H]cAMP. CAR1 A208 (thymidine auxotroph) cells (Sun and Dev- 
reotes, 1991) were cotransformed with cAR2 or cAR3 expression 
plasmid with pGEM 26-6 (gift of  R. Firtel) in a  3:l (pg:pg) ratio and 
selected for growth in unsupplemented HL-5 media. Transformant 
clones were screened by immunoblot. Cells expressing high  levels of 
cAMP binding sites were used for further experiments. 
cAMP Binding Assays-CAMP binding was performed in the ab- 
sence and presence of ammonium sulfate (AS) as described (Van 
Haastert, 1985a). In brief, 8 X lo6 cells were added to  PB containing 
10 mM dithiothreitol, 10 nM [3H]cAMP, and various concentrations 
of cAMP or cyclic nucleotide analog in  a 100-pl volume at 0 "C. Cells 
were incubated 1 min and  then centrifuged for 2 min at 10,000 X g. 
To determine binding in AS,  850  pl of 3 M AS was included in the 
above assay, and after adding cells, 50 p1 of 10 mg/ml  bovine serum 
albumin was added. Cells were incubated 5-7 min and  then centri- 
fuged for 3 min. For both assays, the supernatants were carefully 
aspirated and  the cells resuspended in 80 pl of  0.1 M formic acid. One 
ml of scintillation fluid (Emulsifier, Packard) was then added and 
radioactivity determined. Nonspecific binding was determined by 
adding excess cAMP to  the incubation mixture at a final concentra- 
tion of 1 mM (PB) or 0.1 mM (AS).  Scatchard binding curves were 
best fit using the computer modeling programs, LIGAND (Munson 
and Rodbard, 1980) and Pfit (Elsevier). For analog studies, 3 different 
concentrations  centering  around the IC6,, of each analog was used 
with data points taken in duplicate. The ICso of each analog was 
tested  in two to  three independent experiments. Correlation matrix 
values were obtained using linear regression analysis. 
Zmmunoblotting-Membranes were prepared by solubilizing 1 vol- 
ume of cells with 9 volumes of a lysis buffer containing 1.5% CHAPS 
and pelleting at 10,000 X g for 20 min (Klein et al., 1985). The pellet 
was resuspended with 10 volumes of lysis buffer without CHAPS and 
centrifuged as above. This pellet was suspended in Laemmli's sample 
buffer (Laemmli, 1970), and 50 p1 of sample was analyzed by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot- 
ted as described (Klein et al., 1987). The blot was probed with a 
polyclonal antiserum (1:lOOO) raised against the peptide, KREPE- 
PERFEKYC," a sequence found in the cytoplasmic loop between the 
putative  transmembrane domains 111 and IV of all three CARS (Klein 
et aL, 1988).2,3 
' C. Saxe, A. Kimmel, and P. Devreotes, manuscript in  preparation. 
R. Johnson, C. Saxe, A. Kimmel, and P. Devreotes, manuscript 
M. Caterina, J. Kim, and P. Devreotes, manuscript in preparation. 
in  preparation. 
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4602 cAMP Receptor Cyclic Nucleotide Specificity in Dictyostelium 
TABLE I 
CAMP derivatives used in this study 
No. Name Abbreviation 
1. Adenosine 3‘:5’-monophosphate cAMP 
2. Adenosine-N’-oxide  3’:5’-monophosphate NI-O-cAMP 
3. 6-Chloropurineriboside 3’:5’-monophosphate 6-CI-PuRMP 
4. 7-Deazaadenosine 3’:5’-monophosphate 7-CH-CAMP 
5. 8-Bromoadenosine 3’:5‘-monophosphate 8-Br-CAMP 
7. 3‘-Deoxy-3’-aminoadenosine 3’:5’-monophosphate 3“NH-cAMP 
9. Adenosine 3’5’-monophosphorothioate, S, isomer (S,)-cAMPS 
10. Adenosine 3’5‘-monophosphorothioate, R, isomer (R,)-cAMPS 
11. Benzimidazoleriboside 3’:5’-monophosphate cBIMP 
12. Purineriboside 3’:5’-monophosphate PuRMP 
6. 2’-Deoxyadenosine 3’:5’-monophosphate 2“H-cAMP 
8. 5’-Deoxy-5’-aminoadenosine 3’:5’-monophosphate 5”NH-cAMP 
13. Inosine 3‘:5’-monophosphate cIMP 
14. Guanosine 3’:5’-monophosphate cGMP 






FIG. 2. Expression  of CAR proteins  in Dictyostelium cells. 
Growing cells transformed with either B18, cAR1, cAR2, or cAR3 
expression vectors (lanes 1-4, respectively) were examined for protein 
expression by immunoblotting with a CAR  common antiserum. CAR1 
migrates a t  40 kDa, cAR2 at  39 kDa, and cAR3 at  62  kDa. 
RESULTS 
Expression and Affinity of CAMP Receptor  Subtypes-Each 
of the  three cAMP receptor subtypes, cAR1,  cAR2, and cAR3, 
were expressed in growing  Dictyostelium  cells. Since at this 
stage, cells express only a low number of cAMP binding sites 
(Klein et al., 1987), each individual receptor can be  expressed 
and studied without interference from the endogenous  recep- 
tors. The expression construct chosen utilizes the actin 15 
promoter which is constitutively active during growth and 
early development (Knecht  et al., 1986).  Cells overexpressing 
CAR1 (denoted CAR1 cells) have  been  previously characterized 
(Johnson  et al., 1991).  cAR2 and cAR3 expression constructs 
were created in a similar fashion and transformed into AX-3 
cells. Transformants were selected and screened for their 
ability to bind [3H]cAMP. One clone (cAR2 cells) or mass 
culture (cAR3 cells) expressing high  levels of cAMP binding 
sites were examined further. 
The presence of each exogenously expressed CAR in growth 
stage transformants was  verified by an immunoblot (Fig.  2). 
Membranes were prepared from whole cells and immunoblot- 
ted with a polyclonal antiserum developed against a common 
peptide sequence present in all  CARS.^ Cells transformed with 
either cAR1, cAR2, or cAR3 (lanes 2-4) had an apparent 
molecular mass of 40, 39, and 62  kDa,  respectively. Each of 
the CAR  cells expressed a similar amount of their respective 
receptor protein, while control cells ( l a n e  1 ) transformed with 
the parent vector, expressed very low levels of endogenous 
CAR1 protein and undetectable levels of cAR2 and cAR3. 
O‘O I E18 
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FIG. 3. Scatchard analysis of CAR cells in phosphate  buffer. 
Receptor affinity was determined by the binding of [3H]cAMP to 
cells in phosphate buffer in the presence of increasing amounts of 
CAMP. The units for bound/free (y-axis)  and bound (x-axis) are nM/ 
sites/cell X 1000 and sites/cell X lo5, respectively. See Table I1 for 
binding parameters. 
Bands present at  45 and 29 kDa are probably nonspecific 
proteins and unrelated to  the transformed plasmids  since they 
appear in each of the cell lines including the vector control, 
which contains a low number of cAMP binding sites (Klein 
et al., 1988). 
We determined the affinity and number of cAMP binding 
sites for each of the CAR cells. [3H]cAMP binding to cells 
under physiological conditions (phosphate buffer, PB) was 
determined and  the  data analyzed by Scatchard plots (Fig. 3 
and Table 11). Growing CAR1 cells and developed vector 
control cells each have  two binding sites of similar affinities 
of approximately 30 and 300 nM (Johnson et al., 1991). CAR1 
cells  expressed  over 3 x lo5 sites/cell, which is about 30-fold 
higher than growing and 4-fold higher than developed B18 
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4603 CAMP Receptor Cyclic Nucleotide  Specificity in Dictyostelium 
TABLE I1 
CAR binding pclrameters in phosphate buffer and ammonium sulfate 
Values for B18 and CAR1 were retrieved from Johnson et al. (1991). Values for cAR2 and cAR3 were determined 
as described in “Experimental  Procedures.” 
Phosphate  Buffer  Ammonium  Sulfate 
Cell Kd Sites/cell K d  Sites/cell 
High LOW High Low High Low High LOW 
f lM XlOOO nM X1000 
B18 40 f 9 350 f 180  17 f 12 58 & 13 1.8 f 0.3 - 96 f 2 
CAR1 25 f 8 230 f 45 
cAR2 
75 f 38 260 2 34 3.5 f 0.3 - 370 f 6 - 
cAR3 
11 f 0.6 - 210 f 3 
41 f 8 2  680f 280 1 6 f  24 2 1 0 2  14 4 . 6 f  2.3 2 2 0 3 8 1  
A208/cAR3 14 f 3 
34 f 11 540 zk 110 
490 f 23  2  f 3 370 k 4 2.9 f 0.6 160 f 37 64 f 7 580 f 76 
- 
a - - - - - 
-, binding not  detected. 
cells. cAR3 cells displayed two binding affinities which were 
lower than cAR1. Of the approximately 2 x 10‘ sites/cell 
expressed, the majority constituted  a low affinity site of about 
500 nM while about 5% were of  20  nM. 
Surprisingly, little cAMP binding in PB was detected in 
two independent cAR2 transformants under physiological 
conditions. The low level of cAMP binding detected did not 
differ significantly from that of control vector cells, which 
contained some binding sites derived from endogenous CAR1 
expression. 10 mM Ca2+, which has been shown to reveal 
additional binding sites  in aggregation state cells (Juliani  and 
Klein, 1977; Van Haastert, 1985b), did not increase the level 
of cAMP binding in  the cAR2  cells. In addition,  filter lysis of 
cellular membranes did not expose additional cAMP binding 
sites  (data  not shown). 
The cAMP binding sites in cAR2 cells and  the high affinity 
sites  in the cAR3 cells could not be attributed to the endoge- 
nous CAR1 present during growth. To demonstrate this, a 
CAR1 null cell line (designated A208, Sun and Devreotes 
(1991)), was transformed with the cAR2 or cAR3 expression 
construct?  Transformants were screened for protein expres- 
sion by immunoblot, and clones which expressed high levels 
of  cAR2 or cAR3 were then assayed for cAMP binding. During 
growth, A208 cells have no detectable cAMP binding (Sun 
and Devreotes, 1991). Since the A208 cells transformed with 
cAR2 (denoted A208/cAR2 cells) showed a small amount of 
cAMP binding (490 f 370 sites/cell at 10 nM [3H]cAMP), 
these binding sites must be attributed to the presence of 
cAR2. The CAR1 null cells expressing cAR3 (denoted A208/ 
cAR3 cells) had binding characteristics similiar to  that of the 
cAR3 cells with the wild-type background (Table 11). Scat- 
chard analysis of these cells demonstrate that both the high 
and low affinity components result from cAR3 expression 
(Fig. 3). 
Previous experiments in developed wild-type cells have 
shown that 3 M AS increases both the affinity and number of 
detectable cAMP binding sites  (Janssens  and Van Driel, 1984; 
Van Haastert, 1985a). The effect of AS on cAMP binding was 
tested  on  all  three CAR cells and was found to vary for each 
(Fig. 4 and Table 11). We have shown previously that AS 
enhances receptor affinity in  both growing CAR1 and devel- 
oped B18 cells by over 30-fold (Kd = 4 nM) and increases the 
number of binding sites  (Johnson  et al., 1991). For the cAR3 
or the A208/cAR3 cells, ammonium sulfate enhanced both 
high and low affinity binding by different extents and in- 
creased the number of cAMP binding sites. The high affinity 
sites increased about &fold to 4 nM, while the low affinity 
sites increased by approximately %fold to 200 nM. In the 
’ R. Johnson, R. Gundersen, J. Milne, S. Turgendreich, and P. 
Devreotes, manuscript in preparation. 
cAR2  cells, AS greatly increased the levels of cAMP binding 
by exposing over 2 x lo5 binding sites/cell of a single affinity 
of 11 nM. 
CAMP Derivatives-The 14 cAMP analogs used in this 
study test various interactions between the ligand and recep- 
tor such as hydrogen and ionic bonding and hydrophobic 
interactions (Fig. 1 and  Table I). W-0-CAMP, 6-Cl-PuRMP, 
7-CH-cAMP, 2’-H-cAMP, 3’-NH-cAMP, and  5”NH-cAMP 
have modifications which prevent  potential hydrogen bonds. 
To test for stereoselective interactions in the phosphate 
moiety, (S,)-CAMPS and  (RJ-CAMPS replace the exocyclic 
oxygens (axial or equatorial, respectively) with a negatively 
charged sulfur atom (Frey and Sammons, 1985). In solution, 
cAMP equally favors either a syn- or anti- conformation 
(Hemmes et al., 1976). Since 8-Br-CAMP exists primarily in 
a syn- conformation (Schweizer and Robins, 1973), one may 
infer the conformation of cAMP when bound to the receptor 
from its relative affinity. Finally, derivatives cBIMP,  PuRMP, 
cIMP,  and  cGMP differ in  their degree of polarity (cIMP > 
cGMP > PuRMP > cAMP > cBIMP) (Van Haastert  et al., 
1983). 
Cyclic Nucleotide  Specificity of  CAR Subtypes-Each of the 
CAR cells was tested in ammonium sulfate for their ability to 
bind 14 cAMP derivatives. values were determined by 
measuring the concentration of derivative which inhibited 
50% of [3H]cAMP binding to the receptors. The data are 
presented as KO, derivative/K0, cAMP ratios (Table 111) and 
6AG values (Table IV). 6AG values are derived from the 
following equation to compare these  results to previous studies 
(Jastorff et al., 1979). 
6AG = RT In Koa derivative/K,, cAMP 
6AG values are expressed in kJ/mol and represent the deriv- 
ative’s reduction of binding energy when compared with the 
binding of CAMP. 
The interactions of all three CARS with cAMP share some 
common features which have been previously noted in studies 
on the endogenous receptors in developed wild-type cells (Van 
Haastert  and Kien, 1983). The low affinity of 6-Cl-PuRMP 
and  3”NH-cAMP indicates that hydrogen bonds are formed 
between the receptor and cAMP at the 03‘ position in the 
ribose ring and  the N6 position in the adenine moiety in all 
three CARS. In addition, since 8-Br-CAMP is primarily in the 
syn- conformation (Schweizer and Robins, 1973), the greatly 
reduced affinity of this derivative suggests that cAMP is in 
an anti- conformation when bound to  the receptors. However, 
the poor affinity of this analog may result from the bromine’s 
effect on the electron distribution in the purine ring or steric 
hindrance as well. 
Receptor interactions varied at the exocyclic  oxygens in the 
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FIG. 4. Scatchard analysis of CAR cells  in ammonium sulfate. Receptor affinity was determined by the 
binding of [3H]cAMP to cells in 3 M ammonium sulfate in the presence of increasing amounts of CAMP. The  units 
for bound/free (y-axis) and bound (x-axis) are nM/sites/cell x 1000 and sites/cell X lo’, respectively. See Table I1 
for binding parameters. 
TABLE I11 
Specificity of  CAR subtypes in ammonium sulfate and phosphate buffer 
K,, derivative/Kw cAMP ratios for WT-D were derived from Van Haastert  and Kien (1983). Ratios for CARS 
were determined as described under “Experimental Procedures.” 
Derivative” 
Ammonium  Sulfate  Phosphate  buffer 
WT-D CAR1 cAR2  cAR3  A208IcAR3 CAR1 CAW 
1. cAMP 1 1 1 1 1 1 1 
2. NL-0-CAMP 58 51 3 21 68 140 
3.6-CI-PuRMP 620  370 950  160 70 1100 3300 
4. 7-CH-CAMP 350  230 390  110 - 100 98 
b -
5. 8-Br-CAMP 180‘ 180 50 44  20 220  270 
6. 2”H-CAMP 12 6 3 2 3 21 31 
7. 3”NH-CAMP 810 400  360 130 - 720 1500 
8. 5”NH-cAMPd 7 18 19 23 
3 9. (S,)-CAMPS 110 29 5 
120 10. (&)-CAMPS 97 180 58 - 180 500 
- - - 
1 68 15 
11. cBIMP 160 130 230 28 - 580 930 
12. cPuRMP 1200 1000 660 200 - 3400 8300 
13. cIMP 14000 >10000 2700 >loo00 - 5500 11000 
14. cGMP 22000 >10000 2000 >loo00 - 10000 30000 
a See Fig. 1 and Table I. 
* -, not determined. 
e Value differs from that of Van Haastert  and Kien (1983). 
Data from one experiment. 
phosphate moiety of CAMP. CAR1 bound (S,)-CAMPS and derivatives  relative to cAMP  suggests that there are  important 
(R,)-CAMPS, which replace an axial or equatorial oxygen interactions at both exocyclic  oxygens. In contrast, both cAR2 
respectively with a sulfur atom, with approximately equal and cAR3 bound (S,)-CAMPS with 6- and 30-fold higher 
affinity. The loss of 8-10 kJ/mol  binding  energy  for these two affinity, respectively, than cAR1,  and  both  bound (R,)cAMPS 
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cAMP Receptor Cyclic Nucleotide  Specificity in Dictyostelium 
TABLE IV 
Specificity  of  CAR subtypes in ammnium sulfate and phosphate buffer 
6AG values  for  WT-D  and  polarity were derived  from Van Haastert  and  Kien (1983). 8AG values for CARS were 
determined as described in “ExDerimental  Procedures.” 
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Ammonium sulfate Phosphate buffer 
Derivative” 
WT-D CAR1 cAR2 cAR3 A208IcAR3 CAR1 cAR3 
Polarity 
1. cAMP 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
2. N’-0-CAMP 9.2 8.9 2.5 6.9 9.6 11.2 
3.6-Cl-PuRMP 14.6 13.4 15.6 11.6 9.6 15.8 18.3 2.06 
-4.49 
4. 7-CH-CAMP 13.3 12.4 13.5 10.8 - 10.5 10.4 0.36 
b -
5. 8-Br-CAMP 11ac 11.7 8.9 8.6 6.9 12.2 12.7 1.98 
6. 2”H-CAMP 5.6 4.2 2.6 2.0 2.6 7.0 7.8 




4.5 2.2 2.3  2.8 - - - 
9. (S,)-cAMPS 
-1.65 
10.7 7.7 3.5 2.5 -0.4 9.5 6.1 1.63 
11. cBIMP 11.5 11.1 12.4 7.5 - 14.4 15.5 2.75 
12. PuRMP 16.0 15.7 14.7 12.0 - 18.4 20.5 -0.46 
13. cIMP 21.7 21.4 17.9 21 - 19.5 23.6 
14. cGMP 22.7 22.1 17.2 22.7 - 20.9 23.6 -3.21 
10. (R,)-cAMPS 10.8 10.4 11.8 9.2 - 11.8 14.1 0.66 
-3.41 
See  Fig. 1 and  Table I. 
e 6AG value  differs  from that of Van Haastert  and Kien (1983). 
* -, not  determined. 
Data  from  one  experiment. 
with affinities similar to that of CAR1 (Table 111). In the 
A208/cAR3  cells, where the low levels of CAR1 were absent, 
cAR3 bound (S,)-CAMPS as well as or better than cAMP 
(Fig. 5). This suggests that both cAR2 and cAR3 lack a 
stereoselective interaction at the axial exocyclic  oxygen that 
is  present  in cAR1. The  nature of this interaction  is probably 
not ionic, since a loss of about 25 kJ/mol binding energy 
would  be expected. Steric  disruption is a more likely expla- 
nation since a  thio-substitution of an exocyclic  oxygen  would 
occupy  more space. 
The hydrophobic cleft which binds the adenine ring (Van 




-10 -g 4 -7 4 -5 
Log concentration (M) 
FIG. 5. Inhibition of [SH]cAMP binding by  cAMP and (&)- 
CAMPS on CAR1 and cAR3/A208 cells in ammonium sulfate. 
The  binding of [3H]cAMP to CAR1 ( A )  or cAR3/A208 ( B )  cells was 
inhibited by  increasing concentrations of cAMP (filled squares) or 
(SJ-CAMPS (open  sqwres). 
three receptors. Fig. 6 plots the relative binding energy of five 
derivatives (cIMP, cGMP, PuRMP, 6-Cl-PuRMP, cBIMP) 
as a function of their relative polarity in comparison with 
CAMP. As shown previously in developed wild-type cells, the 
polarity of these derivatives is negatively correlated with 
binding energy. In addition, these compounds are missing the 
N6 amino group in  the adenine ring. The loss of this amino 
group raises the binding energy by about 15 kJ/mol relative 
to CAMP. When this energy increment is subtracted away, 
the binding energy of W-0-CAMP, which has the N6 amino 
group but is very polar, fits this correlation well. Hence the 
adenine  ring is thought to rest in a hydrophobic pocket. 
All three CARS bound these analogs similarly in that  the 
loss of the N6 amino group contributed an increase of about 
15 kJ/mol in binding energy, However, the nature of the 
hydrophobic cleft differed for each CAR as reflected in the 
slope of the lines. Both CAR1 and cAR3  have large negative 
slopes (-1.78 and -1.96, respectively), whereas cAR2 has  a 
slope that is 3 times smaller (-0.622). These  data suggest that 
the adenine moiety is bound in  a cleft of the receptor which 
is more hydrophobic for CAR1 and cAR3 than for cAR2. The 
loss in hydrophobicity in cAR2  may  be caused by changes of 
amino acid residues in the cleft from a nonpolar to polar 
nature. 
The analog specificity of  CAR1 and cAR3  was also examined 
in phosphate buffer (Tables I11 and IV). cAR2 cells were not 
included in  these  studies because of the low number of cAMP 
binding sites detected in PB. In comparision with specificity 
studies performed in ammonium sulfate, both CAR1 and cAR3 
maintain the general order of analog specificity in phosphate 
buffer with two exceptions. 7-CH-CAMP showed increased 
affinity, while cBIMP had reduced affinity relative to the 
other cAMP analogs. Interestingly, the relative binding affin- 
ities of the derivatives were not influenced by ammonium 
sulfate for CAR1 but were enhanced for cAR3. In addition, 
while adenine  ring polarity negatively correlated with binding 
affinity, the slopes were less steep (data  not shown). W-O- 
CAMP, however, does not fit this correlation as well; its high 
polarity cannot account for all of the loss in binding energy. 
Some analogs were also tested on the A208/cAR3 cells 
which lack CAR1 (Tables I11 and IV). Since cAR3 is a low 
affinity receptor, the low levels of the endogenous, higher 
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cAR1 cAR2 cAR3 
I I 
-5 0 5 -5 0 5 - 5  0 5 
Polarity (W/mole) 
FIG. 6. The  dependence of binding affinity on the polarity of some cAMP derivatives  varies between 
CAR subtypa. For  each  graph, filled squares represent  binding  data  in  ammonium  sulfate from Table IV for N- 
0-CAMP (2),  cIMP (13), cGMP (14), PuRMP (12) ,  cAMP (I), 6-C1-PuRMP (3), cBIMP (11) in  order from left 
to right. Linear regression  analysis of the top solid line shows the  strong  influence of polarity on binding affinity 
for CAR1 and  cAR3  (slope = -1.67, r = -0 .986  and  slope = -2.17, r = -0.95,  respectively) but less so for cAR2 
(slope = -0.652, r = -0.86).  These  derivatives  are  all  missing  the  N6  amino  group which contributes about 16, 
15.3,  and 14 kJ/mol,  respectively,  to  the  binding  energy of cAR1,  cAR2,  and CAM. Subtraction of this binding 
increment  yields the open squares. Linear  regression  analysis of the bottom dashed line (which includes N - O -  
CAMP)  gives a similar  slope for each CAR (cAR1, slope = -1.78, r = -0.988;  cAR2,  slope = -0.622, r = -0.887; 
CAM, slope = 1.96, r = -0.946). 
TABLE V
Correlation matrix of the BAG values of derivatives of CAMP binding 
proteins in Dictyostelium 
bAG values for WT-D, CAK, and ePDE were derived from Van 
Ments-Cohen and  Van Haastert  (1989). 
WT-D CAR1 cAR2  cAR3 CAK ePDE 
WT-D  1.0  0.99 0.87 0.95  -0.32  0.21





1.0 0.86 -0.33 0.24 
1.0 -0.21 0.07 
1.0 0.01 
1.0 
affinity CAR1 present in growing wild-type cells may affect 
the measurement of the  true nucleotide specificity of cAR3. 
In AS, the relative nucleotide specificity of cAR3 appears 
similiar in both  sets of cells, but because the ICso for cAMP 
is larger in  the A208/cAR3 cells, the relative bAG values are 
smaller. These same analogs were tested on the A208/cAR3 
cells in phosphate buffer and gave similiar results to  the cAR3 
cells (data  not shown). 
Comparison of cARs with Other CAMP-binding Proteins- 
The analog specificities of the  three cARs were compared with 
each other, the endogenous receptors in aggregation stage 
cells (WT-D)  and two  CAMP-binding proteins  in Dictyoste- 
lium: the regulatory subunit of cAMP dependent protein 
kinase A (CAK) and extracellular phosphodiesterase (ePDE). 
As shown in  Table V, the pharmacological specificity of the 
three CAR subtypes were highly correlated and formed a group 
of CAMP-binding proteins. Similar to previous results (Van 
Ments-Cohen and Van Haastert, 1989), cAMP receptors were 
distinct from other CAMP-binding proteins in Dictyostelium 
since there was no correlation with either CAK or ePDE. As 
expected, CAR1 was most similar to  the endogenous receptors 
in developed wild-type cells. The developmental expression of 
CAR1 protein correlates with the increase of cAMP binding 
sites during early development and  the major band photo- 
affinity labeled with 32P-8-N3-cAMP at 6 h of development is 
CAR1 (Klein et al., 1987). However, (S,)-CAMPS was of higher 
affinity in CAR1 cells than  in developed wild-type cells. In 
addition, our studies showed 8-Br-CAMP to have 3.3 kJ/mol 
less binding energy in developed wild-type cells than previ- 
ously reported by Van Haastert  and Kien (1983) (Table IV). 
DISCUSSION 
We have examined the affinity and cyclic nucleotide spec- 
ificity of three cAMP receptor subtypes by expressing each 
individually in growing Dictyostelium cells. Each receptor has 
a different affinity for cAMP in phosphate buffer and  the 
binding parameters of each is uniquely influenced by ammo- 
nium sulfate. The cyclic nucleotide specificity indicates that 
all  three receptors comprise a family of CAMP-binding pro- 
teins, but each CAR interacts with cAMP in a slightly different 
manner. 
The affinity of the  three CAR subtypes in  phosphate buffer 
vary greatly. CAR1 affinity is similiar to the endogenous 
receptors in developed  AX-3 cells (Johnson et al., 1991). The 
majority of cAR3 binding, however, has an affinity of approx- 
imately 500 nM that  is about 2-fold  lower than cAR1. cAMP 
binding sites of low affinity, termed C sites, have been de- 
tected in wild-type NC-4 cells (Van Ments-Cohen et al., 1991). 
The exposure of aggregation competent cells to UM levels of 
cAMP for several hours depletes the cells of CAR1 mRNA 
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and protein, yet approximately 5 X lo3 cAMP binding sites 
still persist. The Kd of these remaining sites is near 700 nM 
which is  similar to  the affinity of cAR3. Furthermore, cAR3 
is maximally expressed in mound stage c e k 3  This evidence 
suggests that C sites  are cAR3. 
The very low level of cAMP binding in cAR2 cells under 
physiological conditions (PB)  is intriguing. It is possible that 
cAR2 has a very low affinity for CAMP. Our binding assay in 
PB would be unable to detect affinities above 5 p~ because 
of the high levels of nonspecific binding. Indeed, cAR2 is a 
functional receptor since the A208/cAR2 cells display several 
CAMP-stimulated responses in uiuo.' This suggests that cAR2 
is  on  the cell surface and  at least a fraction of the receptors 
are  in a functional  state. Upon exposure to ammonium sulfate, 
all of the cAR2 sites  appear to be converted to a high affinity 
form. The origin of this phenomenon can now  be examined 
by creating cARl/cAR2 chimeric proteins to determine which 
domains of cAR2 dictate this unusual behavior. 
Since each CAR may mediate different signal transduction 
pathways during development, it would  be useful to stimulate 
one receptor subtype selectively and examine subsequent re- 
sponses. Two analogs, N-0-CAMP and (S,)-CAMPS, are 
sufficient to distinguish the receptor subtypes. CAR1 has a 
lower affinity for both of these derivatives relative to the 
other two CARS.  cAR2 binds N-0-CAMP with about  17-  and 
7-fold greater relative affinity than CAR1 and cAR3, respec- 
tively. cAR3 has a relative affinity for (S,)-CAMPS that is 
30-fold higher than  that of  CAR1 (Fig. 5 ) .  In addition, cAR3 
binds  cBIMP by approximately 10-fold higher relative affinity 
than cAR2. Therefore to examine a response in, for instance, 
mound stage cells where both CAR1 and cAR3 are p r e ~ e n t , ~  
(S,)-CAMPS could be used to discriminate between the two 
subtypes. cAR3 has a 2-fold lower affinity for cAMP but a 
30-fold higher affinity for (SJ-CAMPS than cAR1. (SP)- 
CAMPS should activate cAR3 at concentrations 15-fold lower 
than for cAR1. 
A recent  report (Ma and Siu, 1990) has suggested that a 
cAMP receptor different from CAR1 mediates the expression 
of gp80 in Dictyostelium. The cyclic nucleotide specificity of 
the  three CAR subtypes do not  match that of this different 
receptor. However, the authors' experiments were performed 
on dense suspensions of cells, and no precautions were taken 
to control  either self-amplification or phosphodiesterase ac- 
tivity. More analogs will need to be tested to determine 
whether gp80 expression is mediated by an unidentified cAMP 
receptor. 
While the  three CARS have approximately 60% sequence 
identity within the putative  transmembrane  and loop regions 
(Saxe et al., 1991a), we are unable to localize a cAMP binding 
site  or account for the differences in analog specificity by the 
differences in  amino acid sequences alone. Each of the CARS 
has been photoaffinity labeled with [32P]8-N3-cAMP (Thei- 
bert et al., 1984, data not  shown),  but the labeled residue(s) 
has not been identified. We are now attempting to isolate 
labeled peptides from the CARS and  determine  their sequence. 
Furthermore, random mutagenesis of each CAR may deter- 
mine regions within the receptors that  are critical for binding. 
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